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Recent years have witnessed the fascinating development of imaging
approaches to studying neural activities; this progress has been
based on an influx of ideas and methods from molecular biology
and optical engineering. Here we review the design and application
of genetically encoded indicators for calcium ions, membrane
potential and neurotransmitters. We also summarize common
strategies for the design and optimization of genetically encoded
neural activity indicators.

© The authors 2018. This article is published with
open access at journals.sagepub.com/home/BSA
Creative Commons NonCommercial-NoDerivs
CC BY-NC-ND: This article is distributed under the terms
of the Creative Commons Attribution-NonCommercialNoDerivs 4.0 License (http://www.creativecommons.org/
licenses/by-nc-nd/4.0/) which permits non-commercial use,
reproduction and distribution of the work as published
without adaptation or alteration, without further
permission provided the original work is attributed
as specified on the SAGE and Open Access pages
(https://us.sagepub.com/en-us/nam/open-access-at-sage).

KEYWORDS
calcium imaging, neural activity, membrane potential
probe, neurotransmitter reporter

1

Introduction

Imaging the activity of a specific group of neurons
in real time has long been a goal of neuroscientists.
Many chemical indicators have been developed to
monitor neuronal activities by converting intrinsic
parameters of neuronal activity into optical signals
such as fluorescence changes.
A major goal of neuroscience is to determine
the precise functions of different neuronal cell
types [1, 2]. However, except for a few semigenetically encoded indicators, chemical indicators
are unable to target specific cell types in the living

mammalian brain [3]. Furthermore, the loading
procedure has limited the usage of chemical
indicators. Genetically encoded neural activity
indicators (GENAIs) are a class of biological
molecules that can indicate neural activity, usually
through changes in fluorescence. Compared with
synthetic chemical indicators, GENAIs can be
expressed in cells, thus facilitating long-term
observation of individual cells [4] while enabling
the targeting of specific cell types through genetic
techniques.
GENAIs can be classified into several groups
according to their usage (Fig. 1):
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intensity difference ΔI between two image areas,
divided by the average image brightness I , as
shown in the following equation:

C

Figure 1

Classification and common strategies of neural activity

indicators. (a) GENAIs can be classified into calcium indicators
(GECIs), voltage indicators (GEVIs) and synaptic transmission
indicators (GESTIs) by their target physical parameter. These signals
could be transformed into fluorescence signal by (b) amplifying
the signal induced structural variation by conformation-sensitive
fluorescence protein such as circularly permuted FP (cpFP, upper)
or fluorescence resonance energy transfer (FRET, lower). (c) Hybrid
neurotransmitter indicator CNiFER senses its ligand by GPCR
and indirectly reports such signal by genetically encoded calcium
indicator TNXXL. (d) Archaerhodopsin based GEVI could directly
transform the voltage variance signal to optical signal without other
additional structure.

(1) Genetically encoded calcium indicators
(GECIs), which sense the concentration of
Ca2+ ions, a second messenger that faithfully
indicates neural activity;
(2) Genetically encoded voltage indicators
(GEVIs), which can be used to visualize
changes in neuron membrane potential.
(3) Genetically encoded synaptic transmission
indicators (GESTIs), which sense the presence
of common neurotransmitters and provide a
fluorescence readout.
GENAIs usually indicate neural activity
through fluorescence changes. Because most
signals generated by GENAIs are recorded by
optical systems, either traditional cameras or
sophisticated microscopes, optical performance
is the most critical feature of GENAIs. Some
important factors are summarized below (Fig. 1).
Signal intensity and signal-to-noise ratio.
The contrast of an image is proportional to the

I 1  I 0 ΔI

.
I
I

In fact, contrast is often the only output that can
be measured from a GENAI, because normalizing the captured intensity to an absolute level
of neural activity is difficult. Neural activities
are usually recorded as ∆F/F, the ratio of the
fluorescence intensity to the average recorded
intensity. Without a high-intensity fluorescence
signal source, the measured neural activity is
easily overwhelmed by the noisy background:
the signal I may be too weak to be distinguished
from background noise. In addition, GENAIs
themselves must maintain a high signal-to-noise
ratio (SNR) to distinguish their on and off states.
For a neural indicator designed for in vivo
recording, labeling specificity also substantially
contributes to the final contrast: poor labeling
specificity or densely labeled neurons lead to
high background and neuropil contamination.
GENAIs combined with selective expression
methods and sparse labeling techniques can circumvent this problem and therefore are especially
useful in recording axonal or dendritic activities.
Temporal resolution. Real-time imaging of
certain biological processes requires rapidly responding indicators. In many attempts to improve
GENAIs, the major focus has been enhancing
temporal resolution. If the temporal resolution
of the indicators is insufficient, information loss
occurs and may preclude certain experimental
designs.
Dynamic range. Dynamic range (DR) refers
to the range of target physical values that can be
measured by a GENAI. In most cases, DR is
limited at one end of the range by saturation and
at the other end by random noise or uncertainty
in signal levels, which are often referred to as
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the sensitivity of an indicator. If the DR of the
indicator cannot cover the entire range of a
changing biological parameter, the indicator is
unable to perfectly record the entire biological
process.
Photostability. For most GENAIs using
fluorophores as an output, the readout relies on
fluorescence excitation by a light source. Although
techniques such as non-linear multiphoton excitation can partially decrease phototoxicity and the
chance of photobleaching, photostability remains
a key factor for fluorophores used in long-term
observation. Beside the techniques involving
decreasing the photon energy of the input light
or the intensity or time-span of light exposure,
indicator design using more robust fluorophores
that are less prone to bleaching is another practical
method to obtain high photostability.
Although all GENAIs have the same goal in
transforming neural activity into measurable
optical changes, different strategies have been
used to achieve this goal (Fig. 1). For most
commonly used GENAIs, the design principle
is based on either amplifying the variance of
the protein structure under changing physical
parameters through conformation-sensitive
fluorescence protein (cpFPs, e.g., cpGFP) or
fluorescence resonance energy transfer (FRET),
or through a hybrid sensor system that transcodes
the target parameter representing neural activity
into another physical form that is easier to
visualize. Conformation-sensitive fluorescent
proteins can transcode changes in the conformations of other protein domains in response
to neural activities into changes in the absorption
and emission properties of fluorophores. The most
common GFP-based biosensor in this class relies
on a circularly permuted GFP (cpGFP) developed
by Baird et al. [5]. As shown in Fig. 1(b) (upper),
the calmodulin (CaM) and M13 domain in a
GCaMP molecule, a widely used calcium indicator, switches between non-binding (left) and
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binding conformations (right), and this change
triggers fluorescence emission by cpGFP.
FRET, another way to amplify the conformational changes of protein domains (Fig. 1(b),
lower), involves energy transfer between two
light-sensitive molecules (chromophores) [6].
A donor chromophore, initially in its excited
electronic state, may transfer energy to an acceptor
chromophore through nonradiative dipole-dipole
coupling. Unlike intensity-shift indicators, most
FRET-based indicators change in spectrum when
they are activated. FRET is highly sensitive to
the relative orientation of chromophores as well
as the distance between them [7]. However,
FRET-based neural activity indicators require at
least two fluorophores, and the relatively large
sizes of fluorescent protein domains sometimes
hinder expression vector construction and protein
trafficking.
Some hybrid genetically encoded neural
activity indicators function indirectly through
transcoding the target physical parameter to be
measured into an intermediate form, which in
turn is transformed into an optical signal. These
indicators often consist of a pair of separated
sensing and reporting units working cooperatively. Figure 1(c) shows examples of the hybrid
sensor strategy: a calcium indicator indicates
acetylcholine (ACh) signal indirectly through its
increasing fluorescence intensity in response to a
calcium signal produced by the ACh receptor
pathway [8]. Some other hybrid sensors use
synthetic dye to label the genetically encoded
tag. However, use of this class of hybrid sensors
is limited, owing to the relatively low SNR and
low tissue penetrance of synthetic dye [9].
Beyond these categories, some other genetically
encoded indicators can directly convert activity
signals to fluorescence output. These indicators
are mainly archaerhodopsin or green-absorbing
proteorhodopsin (GPR) based; examples include
Archer and QuasAr voltage indicators.
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2.1 Calmodulin based calcium indicators

Genetically encoded calcium indicators

Quantification of free [Ca2+] changes can be used
as a reliable proxy for neural activity, because
dramatic changes result from action potential
firing and synaptic transmission. Chemical calcium
indicators can sense the concentration changes
of Ca2+ ions, thus indirectly indicating neural
activity. In early practice, such quantification
was widely used in functional in vivo imaging;
however, the complicated loading process and
lack of cell-type specificity have strongly limited
its use. As an alternative, GECIs can be easily
expressed in a specific group of neurons through
genetic techniques and subsequently enable longterm observation, as do other GENAIs (Fig. 2).
Many GECIs use CaM as a sensing module
(GCaMP [9−13], Pericams [14], Cameleons [15]
and FIP-CBSM [16]), whereas most of the remaining
GECIs use TnC, the skeletal muscle troponin C
(TN-L family [17−19], Twitch’s [20]) to indicate
changes in Ca2+ concentration (Table 1).

Figure 2

CaM has a relaxed linear structure in the absence
of Ca2+ binding (Fig. 2). As the concentration of
cellular calcium increases, calcium binding CaM
moves closer to M13, and the conformation of
chimeric proteins switches from a dumbbell-like
extended structure to a compact globular structure [21]. This conformational change in protein
structure can be transcoded into changes in
signal intensity by cpEGFP or FRET. The GCaMP
family is the best-known CaM-cpEGFP based
indicator. Its improved versions, the GCaMP6
series, are able to monitor synaptic calcium
transients in individual dendritic spines over the
course of weeks [11]. The most recently described
member of the GCaMP family, the jGCaMP7
has several derivatives for specific purposes:
jGCaMP7f (“fast”) has an improved SNR and
fast kinetics, whereas jGCaMP7s (“sensitive”) has
slower kinetics but higher sensitivity; jGCaMP7b
(“baseline”) has a high fluorescence baseline for
neuropil imaging, and jGCaMP7c (“contrast”)

Genetically encoded calcium indicators. (a) A cpFP-calmodulin based GECI, the calcium binding cause structural variance of

CaM and M13 domain and amplified through a circularly permuted GFP. (b) FRET-calmodulin based GECI, the calcium-induced structural
variance is reported by a FRET pair. (c) Skeletal muscle troponin C (TnC) based GECI, the calcium-induced structural variance is reported
by FRET between two fluorescent protein domains.
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Table 1 Summary of Genetically encoded calcium indicators.
GECI

Year

Sensing

Reporting

Cameleons

1997

Calmodulin

FRET pair

FIP-CBSM

1997

Calmodulin

FRET pair

Pericams

2000

Calmodulin

cpGFP

GCaMP

2000

Calmodulin

cpEGFP

TN-L15

2004

Troponin C

FRET pair

TN-humTnC

2004

Troponin C

FRET pair

TN-XL

2006

Troponin C

FRET pair

TN-XXL

2008

Troponin C

FRET pair

R-GECO

2011

Calmodulin

cp-mApple

GCaMP6

2013

Calmodulin

cpEGFP

RCaMP

2013

Calmodulin

cp-mRuby

Twitch’s

2014

Troponin C

FRET pair

jRCaMP1a,b

2016

Calmodulin

cp-mRuby

jRGECO1a

2016

Calmodulin

cp-mApple

jGCaMP7

2018

Calmodulin

cpEGFP

has a very low baseline fluorescence level (Dana
et al. https://web.archive.org/web/20180912222414/
https://www.janelia.org/jgcamp7-calcium-indicators).
To decrease scattering and absorption in in vivo
imaging, red-shifted variants of calcium indicators based on the same concept have also been
developed [22−24]. Among them, cp-mApple
based indicators have the drawback of photoswitching problems when they are illuminated
with blue light, whereas cp-mRuby based indicators are more compatible for simultaneous use
with ChR2 [23].
Beyond the cpFP based CaM-M13 indicators,
another important class of widely used calcium
signal indicator tools is a series of fluorescent
indicators called Cameleons (Fig. 2). Cameleons
consist of two fluorophores surrounding a
CaM domain and an M13 domain. When these
domains are brought together through CaM-M13
interaction in presence of Ca2+, FRET between
the blue or cyan mutant GFP and the green or
yellow GFP dramatically increases and indicates
calcium concentration changes and neural activity
[15, 23, 25].

http://bsa.tsinghuajournals.com

2.2 Troponin C based calcium indicators

Skeletal muscle TnC based calcium indicators
are another large family of GECIs (Fig. 2). Most
TnC based GECIs use FRET as their reporting
domain. In some cases, CaM based GECIs have
insufficient calcium sensitivity or have a decreased
dynamic range in certain targeting experiments
[17]; in such cases, TnC based calcium indicators
are an acceptable alternative.
2.3 Specialized GECIs

Some application-specific GECIs have also been
developed in recent years. By combining the
photo-regulated features of photoactivatable (pa)
or photoconvertible (pc) FPs with allosterically
modulated cpFPs, Hoi et al. developed a
“highlightable” GECI that can convert output
spectra by illumination [26]. Through library
screening and structure-guided mutagenesis,
Fosque et al. further developed a calcium modulated photoactivatable ratiometric integrator
(CaMPARI), which can provide a snapshot of
activated neurons by permanently marking
activated indicator molecules under violet light
illumination. With short timescale violet light
illumination, CaMPARI can be used to record
neuron activity, thus providing a powerful tool
for optical functional mapping [27].
Because CaM based GECIs such as GCaMPs
may interfere with gating and signaling of L-type
calcium channels and therefore disrupt Ca2+ dynamics and gene expression, Yang et al. developed
an improved indicator, GCaMP-X, by incorporating an additional apoCaM-binding motif.
GCaMP-X exhibits far fewer side-effects than
regular GCaMP indicators while retaining good
calcium-sensing properties [28]. Because many
GECIs use CaM as their sensing domain and
may have the same drawbacks, this work may
inspire the creation of a series of GECIs with few
side-effects.
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but had poor membrane targeting performance
[32, 33].

Genetically encoded voltage indicators

GEVIs indicate neural activities by allowing for
visualization of neuronal membrane potential
(Fig. 3). The first generation GEVIs, including
FlaSh [29], SPARC [30] and VSFP1 [31], are based
on voltage-gated ion channels. In 1997, Siegel
and Isacoff described the design of the first
GEVI. By fusing a C-terminally disordered GFP
into a voltage-sensitive Shaker K+ channel, they
produced an indicator that shows fluorescence
changes in response to potential changes [29]. In
2001, Sakai et al. designed VSFP1, which is based
on FRET of a pair of GFP mutants (CFP and YFP)
fused to a potassium channel. The FRET efficiency
of the chromophore dipole changes when a
potential change causes the S4 of the channel
to rotate and changes the orientation between
chromophores [30]. In 2002, Ataka and Pieribone
designed SPARC by inserting GFP into a sodium
channel [30]. These early GEVIs showed potential

Figure 3

3.1 Voltage-sensitive fluorescent proteins

A major class of GEVIs, the voltage-sensitive
fluorescent proteins (VSFPs), including VSFP2
and its variants, are based on the paddle domain
of voltage-gated phosphatase (VSP), mainly
Ci-VSP (Fig. 3). In 2007, Dimitrov et al. designed
VSFP2.1 by using Ci-VSP and a fused FRET pair,
which is similar to VSFP1 but exhibits efficient
membrane targeting [34]. In 2008, Lundby et al.
reported VSFP3.1, which is monochromatic and
replaces the slow FRET-based fluorescence
reporting in VSFP2s with voltage-dependent
fluorescence intensity [1, 2]. In 2012, Jin et al.
described ArcLight indicators, which have
substantially improved ∆F/F and consequently
better voltage sensitivity [35]. However, the
kinetics of ArcLight variants, even that of their
fast components, is still relatively slow. In 2014,

Overview of GEVI structural designs. (a) A VSFP based GEVI uses FRET as its reporting module. The structural variance of

VSFP driven by depolarization of membrane potential is reported by fret between two fluorophore domains. (b) An extracellular
cpFP-VSFP based voltage indicator. (c) A FRET-VSFP butterflies chimeric protein design. (d) Fast-dynamics and sensitive single-cpFP based
ASAP. (e) Archaerhodopsin based GEVI, can directly transform the action potential signal to optical signal. (f) Archaerhodopsin-FRET
based GEVI. The emission of FP is quenched by FRET with protonated retinal Schiff base at depolarizing voltage. This method provides
higher fluorescent intensity and higher-method compatibility spectral properties.
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Pierre et al. introduced ASAP1, in which a
different VSP from chicken is used. They chose
a VSD from Gallus gallus because of its shorter
S3-S4 loop, and they fused a cpGFP into Gallus
gallus VSD. Their results showed that ASAP1 has
ultrafast temporal resolution and can track spike
trains of up to 200 Hz (Table 2) [36].
3.2 Opsin-based voltage indicators

Another class of GEVIs using an opsin-based
mechanism was introduced after VSFPs (Fig. 3).
The first prototype, PROPS, was described by
Kralj et al. in 2011 in E. coli. PROPS is based on

a GPR in bacteria that contains a Schiff base
moiety with pH-dependent fluorescence. PROPS
shows different fluorescence intensity at different
induced transmembrane voltages [39]. However,
PROPS does not localize to the eukaryotic
membrane and cannot function as a GEVI [40].
Subsequently, Kralj et al. introduced Arch D95N,
based on Arch, in which bacterial GPR is replaced
with Archaerhodopsin from Halorubrum sodomense.
The photocurrent in wild-type Arch is eliminated
in Arch D95N, and this improved version
can be used in mammalian neurons [40]. The
fluorescence of original Arch must be excited

Table 2 Summary of genetically encoded voltage indicators.
GEVI name

Year

Sensor

Reporter**

ΔF / F (%)

 on (ms)

 off (ms)

References

FlaSh

1997

Shaker (K+ channel)

GFP

−5.1

85

160

[29]

VSFP

2001

Rat Kv2.1 (K channel)

CFP/YFP

1.8

0.74

[31]

SPARC

2002

Rat Na channel

GFP

~ −0.5

0.8

[30]

VSFP2.1

2007

Ci-VSP

CFP/YFP

8.6

15

VSFP3.1

2008

Ci-VSP

CFP

~ −0.6

1.3

Mermaid

2008

Ci-VSP

mUKG/ mKOκ

~ 28

11.8

PROPS

2011

GPR

Same as left

150

4.7

[39]

Arch

2011

Archaerhodopsin 3

Same as left

40

~ 0.5

[40]

Arch D95N

2011

Archaerhodopsin 3

Same as left

60

41

ArcLight Q239

2012

Ci-VSP

pHluorin

ElectricPk

2012

Ci-VSP

cp-EGFP

VSFP-Butterfly 1.2

2012

Ci-VSP

mCitrine/mKate2

4.2

Mermaid2

2013

Ci-VSP

mUKG/mKOκ

MacQ-mCitrine

2014

L. maculans rhodopsin

QuasAr1

2014

QuasAr2

+

+

75

[34]
[37]

70

[38]

[40]

~ −39

~ 21

*

*

~ 22

[35]

−1.2

2.24

2.09

[41]

48.5

~ 1.6*

10.3

[43]

MacQ/mCitrine

~ −20

~ 6.5*

~ 9.6*

[44]

Archaerhodopsin 3

Same as left

32

~ 0.064*

~ 0.10*

[45]

2014

Archaerhodopsin 3

Same as left

90

~ 2.5

~ 1.7

[45]

Archer1

2014

Archaerhodopsin 3

Same as left

85

Archer2

2014

Archaerhodopsin 3

Same as left

60

ASAP

2014

Gg-VSP

cp-EGFP

−17.5

~ 8.6

Ace2N-mNeon

2015

Acetabularia acetabulum
rhodopsin

Ace rhodopsin/
mNeonGreen

−18

FlicR1

2016

Ci-VSP

cp-RFP

[42]

*

*

[46]
[46]
*

[36]

~ 0.68*

~ 1.0*

[47]

6.6

~ 1.1*

~ 1.6*

[48]

*

[49]

*

~ 13

ASAP2f

2016

Gg-VSP

cp-EGFP

~ –25

~ 5.8

~ 8.0

Archon1

2018

Archaerhodopsin 3

Same as left

43

~ 0.83*

~ 1.5*

[50]

Archon2

2018

Archaerhodopsin 3

Same as left

19

~ 0.25*

~ 0.23*

[50]


1
 slow
* These numbers are estimated with    fast
, where  

*

fastcomponentamplitude
.
totalamplitude

** FRET donors and acceptors are separated with a slash.
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under high-intensity illumination, thus posing
a substantial autofluorescence problem. The
mutants Archer1 and Archer2 were later introduced by Flytzanis et al. to improve the properties, especially the fluorescence baseline and
dynamic range of Arch [46]. Compared with
fluorescent protein-based GEVIs, Arch-based
GEVIs typically require 300–800 W·cm–2, whereas
brighter fluorescent protein-based indicators
require 10 W·cm–2 [51]. To circumvent the problem of the low brightness of Arch-based GEVIs,
FRET designs have been developed by fusing
Arch or its mutant with a chromophore, such as
QuasAr2-mOrange [51], to enhance the signal
intensity and achieve high signal intensity, SNR
and temporal resolution. Moreover, some opsinbased GEVIs retain their endogenous protonpumping capability and produce a 1020 pA
outward photocurrent.

Archon1 [50]. Archon1 is improved in multiple
aspects and exhibits excellent localization, SNR,
sensitivity, response speed and photostability,
as well as full compatibility with optogenetic
control [50]. Because action potential has a
millisecond timescale, currently, only state-of-theart sCMOS cameras can provide a sample rate
(~ 1000 FPS) permitting in vivo action potential
imaging. However, these devices are generally
large and are unable to be integrated into headmountable devices for imaging in freely moving
animals, and they usually have a limited field of
view. To remedy these defects, some ongoing
projects aim to build miniature microscopes
capable of high-speed action potential imaging
(https://web.archive.org/web/20180912222322/
http://grantome.com/grant/NIH/R21-EY028381-01).

3.3 Recent progress in action potential imaging

Genetically encoded synaptic transmission indicators

In recent work, in 2018, Piatkevich et al. developed
a robotic cell picker to screen hundreds of
thousands of proteins in a few hours and produced the high-performance opsin-based GEVI

GESTIs are a class of neural activity indicators
that provide a signal response to specific neural
transmitters (Fig. 4). These sensors can be further
categorized into bacterial periplasmic binding

Figure 4

4

Genetically encoded synaptic transmission indicators. (a) GluSnFR, a GltI-FRETbased glutamate indicator. (b) iGluSnFR, a GltI-cpFP

based glutamate indicator. (c) Cell-based neurotransmitter fluorescent-engineered reporters (CNiFERs). (d) Hybrid GPCR-FRET indicators
using biarsenical chemical dye FlAsH as one of its fluorophores. (e) TANGO assay, sensitively reports subtype specific GPCR activation
through cleaving and releasing the transcriptional activator, tTA fused to ligand-activated GPCRs by a TEV protease-human-arrestin chimeric
protein. (f) cp-FP based GPCR neurotransmitter probes which provide superior spatiotemporal precision.
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protein (PBP) based sensors, hybrid sensors and
GPCR-based sensors on the basis of their design
principles (Table 3).
4.1 PBP-based synaptic transmission sensors

PBPs compose a large superfamily of members
that bind various chemicals including neurotransmitters (Fig. 4). One of these proteins,
glutamate-binding PBP (Glt-I) has been used to
build a synaptic transmission sensor. FLIPE [52],
GluSnFR and superGluSnFR [53, 54] resulted
from early attempts to construct a FRET-Glt-I
glutamate sensor. However, the SNR of FRETbased Glt-I sensors was insufficient to resolve
individual responses [53] and hampered in vivo
observation. iGluSnFR, based on combining the
glutamate-binding protein Glt-I with cpEGFP,
became the first practical sensor used to visualize
glutamate dynamics in vivo [55]. Although PBP
based GESTIs cannot be easily modified to sense
Table 3 Summary of Genetically encoded synaptic transmission indicators.
GESTI

Year

Ligand

Sensing

Reporting

GPCR-cam

2003

NE & PTH

GPCR

FRET pair

FLIPE

2005

Glutamate

Glt-I

FRET pair

GluSnFR

2005

Glutamate

Glt-I

FRET pair

NE

GPCR

FRET pair

2006
Adrenergic
muscarinic sensor
TANGO

2008

GPCR
ligands

GPCR

Reporter
genes

M1-CNiFER

2010

ACh

GPCR

TN-XXL

2010
M1, M3, M5
muscarinic sensor

ACh

GPCR

FRET pair

M1-mAChR

2012

ACh

GPCR

FRET pair

iGluSnFR

2013

Glutamate

Glt-I

cpEGFP

D2-CNiFER

2014

DA

GPCR

TN-XXL

α1A-CNiFER

2014

NE

GPCR

TN-XXL

iTANGO2

2017

GPCR
ligands

GPCR

Reporter
genes

GACh

2018

ACh

GPCR

cpEGFP

dLight1

2018

DA & other
ligands

GPCR

cpEGFP

GRAB-DA

2018

DA

GPCR

cpEGFP

http://bsa.tsinghuajournals.com

different neurotransmitters, the sensitivity, temporal resolution and SNR of some of its improved
variants have made it a workhorse in glutamate
functional imaging in the past few years.
4.2 Hybrid synaptic transmission sensors

Attempts to address the limitations of single
GEStIs have yielded several hybrid sensors (Fig. 4).
As a natural receptor for neurotransmitters,
GPCRs have outstanding ligand specificity and
can be easily modified to apply a sensor design
to other homologous receptors. However, the
ligand induced conformation changes of GPCRs
are relatively weak, thus causing difficulties
and insufficient SNR in signal amplification. To
avoid this problem, cell-based neurotransmitter
fluorescent-engineered reporters (CNiFERs) were
introduced by Nguyen et al. to report on extracellular ACh [8] and were extended to dopamine
and norepinephrine reporting by Muller et al.
[56]. CNiFERs are cultured cells engineered to
express the GPCR of the target molecule and the
calcium indicator TN-XXL. GPCRs in CNiFERs
transform neurotransmitter signals into increased
cytosolic [Ca2+] via the IP pathway, and report on
[Ca2+] through readout of the calcium indicator
TN-XXL [8, 56]. CNiFERs can indicate subtype
activity; however, they still require a complex
injection process to be loaded to target sites in
the brain; moreover, they are unable to label
specific genetically defined cell types and cannot
provide sufficient temporal resolution to directly
monitor the transmitter release events on subsecond time scales [57].
Another problem in GPCR-based GESTI design
is that FRET pairs used to amplify conformational
variance signal are large and thus cause protein
trafficking problems. Because chemical dyes are
much smaller than fluorescent proteins, some
hybrid GPCR-based GESTIs use the biarsenical
chemical dye FlAsH (fluorescein arsenical hairpin
binder) to act as one of the fluorophores in the
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FRET pair [13, 58], thereby decreasing the indicator size.
4.3 GPCR-activation-based sensors

Among the GESTIs, GPCR-activation based sensors
(GRABs) are a promising series of GESTIs that
consist of a ligand specific GPCR and a reporter
to amplify the structural variation of the 7-TM
rhodopsin domain of these GPCRs (Fig. 4).
Currently, most GRABs are based on subfamily
A17 rhodopsins, such as the 5-hydroxytryptamine
receptor, dopamine (DA) receptor, adrenergic
receptor and subfamily A18 rhodopsins such
as ACh receptors. Unlike traditional synaptic
transmission indicators, GPCRs are natural homologous receptors for many neurotransmitters,
and their design can be easily applied to other
cognate GPCRs for sensing their ligands.
Beyond the GESTIs used to amplify the ligandbinding signal via the intrinsic GPCR signaling
pathway described in Section 4.2, the TANGO
assay developed by Barnea et al. provides another
practical method to monitor subtype specific
GPCR activity by cleaving and releasing the
transcriptional activator tTA fused to ligandactivated GPCRs via a TEV protease-human
β-arrestin chimeric protein. The tTA dependent
reporter gene can thus be expressed in response
to subtype-specific GPCR activation [59]. The
improved iTANGO2 assay achieves a higher
temporal resolution (on a scale of minutes) than
the original TANGO assay (on the scale of several
hours) by adding a light inducible protease system
to the ligand-gated gene expression system [60].
However, limited by the gene expression, the
temporal resolution of reporter gene-based
methods is still incompatible with the fastest
single molecule indicators. FRET is a common
method to construct high temporal resolution
indicators. Efforts to design dual-fluorescent
protein GPCR indicators have resulted in several
FRET-based GEStIs. FRET-based GRABs have

superior temporal resolution [18, 61], but because
of the relatively small conformational changes
of GPCRs, most of these indicators do not have
ideal temporal-resolution and sensitivity. As
mentioned in Section 4.2, the size of these dualFP FRET indicators is still a problem for in vivo
study. In recent studies creating a high-temporal
solution GPCR-based GEStI, a conformationally
sensitive fluorescent protein has been inserted
in the third intracellular loop of GPCRs, because
the intracellular loop between the TM and TM
undergoes a relatively large conformational
change upon ligand binding. In addition, these
GPCR-based sensors must be carefully designed
to avoid perturbing the intrinsic physiology in the
cell of interest [9]. Jing et al. have constructed the
ACh indicator GACh, which has high sensitivity
(EC50 ≈ 1 μM), high SNR (≈14) and fast kinetics
(   200  800ms ) while maintaining an endogenous receptor level on/off specificity and
photostability [62]. A similar approach has been
applied to the construction of the DA indicator
[57, 63] and several other indicators including
norepinephrine, serotonin, melatonin and opioid
[57]. These single-FP based GRABs enable spatiotemporally precise measurements to indicate their
corresponding neurotransmitters.

5

Discussion

The development of GENAIs in recent decades
has provided powerful tools for cell-type-specific
neuroscience studies. These indicators have been
conceived, constructed and improved to meet
the growing requirements of functional imaging.
Efforts to improve GENAIs have mainly focused
on their optical properties including photostability, fluorescence intensity, signal sensitivity,
dynamic properties and compatibility with
optical neuronal activity manipulating methods.
However, for many real-life applications, all these
requirements cannot be satisfied simultaneously,
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and certain applications may require distinct
properties that could be achieved by a single
indicator. The next generation GENAIs could be
optimized for specific uses, such as the jGCaMP7
series variants, as recently reviewed by Luo et
al. [2]. These variants with different sensitivity,
temporal resolution and baseline intensity can
satisfy the diverse requirements of applications
such as neuropil observation and wide-field
imaging.
Finally, given how the field has developed in
recent years, further developments of GENAIs
that are ultrafast, ultrasensitive and compatible
with manipulation methods are likely to boost
further study of brain function.
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